TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Victim empowerment related to safety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Probable Post Traumatic Stress Disorder (PTSD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical health status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Systolic blood pressure elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of Patients Who Complete Annual Diabetic Eye Screening
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: MdDS Balance Rating Scale (MBRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 Year Recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: 3 Year Recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free rate of remaining lesions
Endpoint domain: Mortality/survival
Primary endpoint: Reduced facial sebaceous gland size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Neuro-behavioral changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quantified blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pelvic floor electromyography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in disease Activity Score in 28 joints (DAS28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-observer agreement and accuracy of BLI system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rumination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with fecal incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with sensation of residual stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of complete response (CR) on day 60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of hypercalcemia
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Composite morbidity-mortality criterion
Endpoint domain: Mortality/survival
Primary endpoint: spontaneous pregnancy rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Full vaccination coverage (2 doses)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nurse-patient therapeutic alliance at discharge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breast Milk Expression Experience Measure (BMEE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Iowa Infant Feeding Attitude Scale (IIFAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cytoreductive surgery rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to Receipt of First HPV Vaccine Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Receipt of Second HPV Vaccine Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in stool bifidobacteria level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Leg Cramps Evaluation Form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first moderate exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time to severe exacerbation (hospitalization)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total step count (average steps/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS-UPDRS3 motor scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to severe-critical ARI requiring hospitalization, oxygen therapy and/or mortality
Endpoint domain: Mortality/survival
Primary endpoint: Days to viral clearance (RT-PCR negativity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to presenting symptom resolution
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain Reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of hospitalized patients aged 65 years or older with cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of hospitalized patients aged 65 years or older with cognitive impairment recognized by healthcare professionals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cortical excitability measured by TEPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Medication for Opioid Use Disorder (MOUD) knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Opioid Overdose knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants requiring pharmacologic treatment of NOWS
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wellbeing change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CFR, IMR, FFR and RFR values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in IVC Tumor Thrombus Extent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IVC TT Size from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total minutes of time spent in Moderate to Vigorous Physical Activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine Specific Gravity (USG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical Adequacy Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of MXA protein in renal biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportions of WHO histological classes of renal biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Composite progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with MRD negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of IgG Antibodies to AlpN Proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean time from discharge decision to actual discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in level of erectile dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in level of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Objective Response Rate of Airway Tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Dipping status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of non-severe and severe COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Multisystem Inflammatory Syndrome in Children (MIS-C)
Endpoint domain: Mortality/survival
Primary endpoint: Postural control parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest-wall compliance (Ccw)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical Success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye Fixation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialytic clearance of p-CS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of EPPA-LOMB from baseline at 7 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of EPPA-LOMB from baseline at 21 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of EPPA-LOMB from baseline at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Evolution of LLS (linear local shortening)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients treated successfully
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Personal Pain Beliefs on Pain Self-Efficacy Questionnaire (PSEQ) at Day 21
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in reflex activity as measured by the H-reflex amplitude (mV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in walking speed (m/s) as measured by the 10-meter Walk Test (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in walking distance (meters) as measured by the 6-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue distribution of 89Zr-NY008
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reepithelialization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Myoelectric activity of cervical muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Craniocervical angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of Intervention Components Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Borg Dyspnea Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MRD negativity/reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in decisional conflict scale (SURE) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Colorectal cancer screening attitude belief scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healthy lifestyle behaviors scale II
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Presence / absence of Erosive Esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ECG change related to position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of central nervous system adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Headache Impact Test (HIT-6) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Desaturations during extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Product tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Product efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Housing Stability
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Education and Vocational Engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in number of prescribed medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in FACIT-Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Serum level of miRNAs223 and HMGB1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial symmetrization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of positive MRI sequences along with positive tumor biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: number of negative MRI sequences along with negative tumor biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ovarian reserve marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Peak nasal inspiratory flow change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Nasal blood flow change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Cytokine levels (IL-17, IL-10, IL-12p70, IFN-γ, IL-4, IL-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: The change of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total healthcare expenditures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: First occurrence of symptomatic COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Participants with one or more adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Participants with an AE leading to discontinuation of study intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Time to sustained recovery of COVID-19-related signs/symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of tool in nodule
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of grade 2-4 acute Graft vs Host Disease (GVHD) requiring systemic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: First applanation velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in implant stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Efficacy of intrathecal dexmedetomidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hearing disability as measured by the Speech, Spatial and Qualities Hearing Scale (SSQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervico cranial angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional neck status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass (physique) - Bioelectrical impedance analysis (BIA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass (physique) - Phase Angle (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass (physique) - BIVA vector analysis (Cole Cole graf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in score of life quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in score of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Urine Volatile Organic Compounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of bacteriuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Daily Step Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Early Withdrawal
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: postoperative 12 month mRS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: postoperative 12 month aneurysm occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child behavior regulation (Infant Externalizing Questionnaire) at 6 months post-intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child diurnal cortisol rhythm at 6 months post-intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the plasma concentration-curve from zero to the last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in WHO-5 Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline of microcirculatory flow index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Delta of EORTC Proctitis Module (PRT20) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gut barrier integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Secondary Traumatic Stress Scale for Social Media Users
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in adiposity (% fat body mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in blood glycated hemoglobin (HbA1c) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: self-assessed Simplified Psoriasis Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Dermatology Life Quality Index (DLQI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cerebral Performance Category Score 1-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the diameter of the pelvic veins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in the duration of pelvic venous reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Postprocedural pain
Endpoint domain: Adverse events/effects
Primary endpoint: Cycle constant work-rate exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Margin status of WLE specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Gait - Walking velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait - Step Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait - Step Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait - Stride Width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait - Cadence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait - Foot Fall Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROX index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mother-to-Infant Bonding Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain relief from acute migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phase II clinical recommended dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Screening in Pediatrics Tool (SSPedi) total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breastmilk metabolite composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Subjects with Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Concordance between physician's diagnosis and tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Agreement of detected malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of diabetes mellitus (DM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in 24-hour SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale-Cognition Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completeness of resection of intracavitary lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Suck/swallow/breathe coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: apparent conversion rate constant kPL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes